Clostridium septicum myonecrosis in congenital neutropenia

Pediatrics. 2004 Dec;114(6):e757-60. doi: 10.1542/peds.2004-0124.

Abstract

Severe congenital neutropenia (SCN) and Clostridium septicum myonecrosis is an uncommon and life-threatening association requiring urgent combined aggressive medical and surgical management. We report 2 cases of SCN (1 with known Kostmann's syndrome and 1 not known at presentation to have a congenital neutropenic disorder but subsequently received a diagnosis of cyclic neutropenia) who presented with spontaneous C septicum myonecrosis. The cases highlight the importance of response to recombinant human granulocyte colony-stimulating factor in obtaining a satisfactory outcome for these patients. Early, empirical use of recombinant human granulocyte colony-stimulating factor in patients who are suspected of having a congenital neutropenia and who present with life-threatening sepsis is recommended.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child, Preschool
  • Clostridium / isolation & purification*
  • Clostridium Infections / complications*
  • Fatal Outcome
  • Female
  • Gas Gangrene / etiology
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Infant
  • Male
  • Muscles / pathology*
  • Necrosis / etiology
  • Neutropenia / complications
  • Neutropenia / congenital*
  • Neutropenia / drug therapy
  • Recombinant Proteins

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor